Unexplained infant and child death: a review of sudden infant death syndrome, sudden unexplained infant death, and child maltreatment fatalities including shaken baby syndrome

Newton, A.W.; Vandeven, A.M.

Current Opinion in Pediatrics 18(2): 196-200

2006


ISSN/ISBN: 1040-8703
PMID: 16601503
DOI: 10.1097/01.mop.0000193296.32764.1e
Document Number: 287759
Effective therapeutic options have not existed for prostate cancer progressing after androgen deprivation therapy until very recently. Docetaxel based chemotherapy has been demonstrated to extend survival in 2 large randomized trials. These studies have provided the impetus to combine docetaxel with novel biologic agents to further consolidate the gains in long-term outcome. With the arrival of exciting agents including vaccines, monoclonal antibodies, bone-targeted drugs, antisense oligonucleotides, antiangiogenic drugs, and small molecule receptor tyrosine kinase inhibitors, the future of prostate cancer therapy appears promising.

Document emailed within 0-6 h
Secure & encrypted payments